
Medigene licences CD40L-CD28 costimulatory switch receptor
Medigene has licences the global exclusive rights for CD40L-CD28 costimulatory switch receptor from the Helmholtz Centre Munich. Financial details...

Swiss Biotech Report: Sunrise, not sunset, is the feeling of the hour
The latest Swiss Biotech Report, published at the end of April by the Swiss Biotech Association (SBA) in collaboration with EY and eight other...

eXmoor Pharma Ltd raises US$35m
The financing of eXmoor Pharma Ltd. was led by new investor Kineticos Ventures and existing investor MVM Partners to help launching...

FAO presents food safety assessment on cell-based protein products
With more than 100 companies, including Israel's Aleph Farms, Holland's Mosa Meat and the UK's Higher Steaks Ltd., active in the future market of...

Carbios SAS set to licence and expand PET recycling
Carbios SAS has announced "excellent outputs" from its demonstration plant in Clermont-Ferrand and its advanced engineering study for the...

LanzaTech and Plastipak produce greener PET
The PPKNatura resin might safe up to 30% carbon emissions because it replaces petroleum-based monoethylene glycol (MEG), together with terephtalic...

Dutch State to sell share capital of Intravacc BV
Two years after the establishment of the private company Intravacc BV (Bilthoven, The Netherlands), the sale of the former Netherlands Vaccine...